Avastin®, Mvasi®, Zirabev®
Bevacizumab (Avastin®, Mvasi®, Zirabev®) is used to treat patients with glioblastoma, renal cell carcinoma, cervical cancer, ovarian cancer, fallopian tube cancer, primary peritoneal cancer, hepatocellular carcinoma, and non-small cell lung cancer (NSCLC).
Our Medication Sheet
This sheet is available to download as an Adobe PDF.Get Bevacizumab (14 Day) Medication Sheet
Get Bevacizumab (21 Day) Medication Sheet